Anti-D Immunoglobulin (RhIg) in Kenya

Product Summary

Anti-D immunoglobulin (RhIg) is a life-saving medication used to prevent Rh sensitization in Rh-negative pregnant women carrying Rh-positive babies. It stops the mother’s immune system from producing antibodies that attack fetal red blood cells, preventing hemolytic disease of the newborn (HDN). In Kenya, it is administered as an intramuscular injection at specific times during pregnancy and postpartum.

Key Uses

1. Antenatal Prophylaxis:
   • Dose: 1500 IU (300 µg) at 28 weeks’ gestation.
   • Purpose: Prevents sensitization during the third trimester.
2. Postpartum Prophylaxis:
   • Dose: 1500 IU within 72 hours of delivery (if baby is Rh-positive).
   • Purpose: Blocks antibody formation after fetal-maternal hemorrhage.
3. Post-Event Prophylaxis:
   • After miscarriage, abortion, amniocentesis, or abdominal trauma.
   • Dose: 1500 IU within 72 hours.

Composition

• Active Ingredient: Human anti-D (Rh) immunoglobulin.
• Form: Solution for intramuscular injection (pre-filled syringes or vials).
• Strengths: 1500 IU (300 µg) per dose.

How to Use

Administration

• Route: Deep intramuscular injection (deltoid or gluteal muscle).
• Timing:
  • Antenatal: Single dose at 28 weeks.
  • Postpartum: Within 72 hours of delivery.
• Critical Notes:
  • Blood Typing: Confirm mother is Rh-negative and baby is Rh-positive (post-delivery).
  • Storage: Refrigerate (2–8°C); do not freeze.

Dosage Adjustments

• Higher Doses: For large fetal-maternal hemorrhage (e.g., 3000 IU if hemorrhage >15mL).
• Repeat Doses: Not routinely needed unless sensitization risk persists.

Potential Side Effects

• Common: Injection-site pain, mild fever, headache.
• Rare:
  • Allergic reactions (rash, anaphylaxis – monitor for 20 mins post-injection).
  • Transient viral infection risk (all immunoglobulins carry minimal risk).

Precautions

• Avoid if:
  • Mother is already Rh-sensitized (has anti-D antibodies).
  • Baby is Rh-negative (no sensitization risk).
• Pregnancy/Breastfeeding: Safe (no fetal risk).

Access in Kenya

Challenges in Kenya

1. Stockouts:
   • Public facilities often lack supplies (especially rural areas).
   • Solution: Book early at ANC; request referral to stocked facilities.
2. Cost Barriers:
   • Private-sector costs are prohibitive for low-income families.
   • Solution: Use NHIF (covers 80% at accredited facilities).
3. Cold Chain Requirements:
   • Power outages in rural clinics compromise storage.
   • Solution: Use solar-powered refrigerators (e.g., UNICEF-supported facilities).
4. Awareness Gaps:
   • Many women miss doses due to lack of counseling.
   • Solution: Community health worker education programs.

Frequently Asked Questions

1. Is Anti-D available over-the-counter?
   No – prescription-only; administered by trained health workers.

2. What if I miss the 28-week dose?
   Take ASAP – even if late. Postpartum dose is still critical.

3. Can I get it if I deliver at home?
   No – requires facility delivery. Plan for hospital birth.

4. Does NHIF cover Anti-D?
   Yes – at accredited public/private hospitals (covers 80% after co-payment).

5. Are there alternatives?
   No – Anti-D is the only proven preventive treatment for Rh sensitization.

Who Needs Anti-D?

• All Rh-negative pregnant women (unless already sensitized).
• After events causing fetal-maternal hemorrhage (e.g., miscarriage, trauma).